Tue.Jun 04, 2024

article thumbnail

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Fierce Pharma

A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has retu | A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has returned with an endorsement in obesity.

315
315
article thumbnail

Bayer taps Samsung wearables for menopause sleep study

pharmaphorum

Sleep disturbances are one of the most common and disruptive symptoms in menopausal women, but not enough is known about the causes, and current sleep aids are often ineffective. To plug that gap, Germany’s Bayer has joined forces with electronics group Samsung to carry out an observational study on sleep disturbances during menopause (SDM), tapping into the South Korean company’s position as one of the world's largest producers of consumer electronics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lawmakers request intelligence briefing on CDMO GenScript, Legend Biotech's ties to China

Fierce Pharma

For several months, a U.S. security crackdown on biopharma firms suspected to be linked to the Chinese Communist Party (CCP) has continued to gain steam. | For several months, a U.S. security crackdown on biopharma firms suspected to be linked to the Chinese Communist Party has continued to gain steam. Now, several new names could be feeling the heat.

Biopharma 292
article thumbnail

Abbott’s OTC glucose monitor ‘will grow the market’

pharmaphorum

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and analysts think uptake by patients is now poised to take off.

Marketing 107
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Amarin's CEO resigns, leaving former interim chief to take over struggling drugmaker

Fierce Pharma

After Amarin's tussle with investor group Sarissa Capital led to a restructuring and a board shuffle, the struggling drugmaker is undergoing its third CEO shake-up in just over a year.

220
220
article thumbnail

As Interest in GLP-1s Explodes, People Living With Diabetes Need Structured Support To Ensure Effective Use

MedCity News

By working together to build an ecosystem of support around people with diabetes, the healthcare system as a whole can ensure that no one slips through the cracks. The post As Interest in GLP-1s Explodes, People Living With Diabetes Need Structured Support To Ensure Effective Use appeared first on MedCity News.

More Trending

article thumbnail

Exploring the Potential of mRNA (BIO 2024)

PharmaTech

Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.

115
115
article thumbnail

Climate change may aggravate multiple sclerosis

Pharmaceutical Technology

A June 2024 literature review has revealed that climate change has the potential to intensify MS symptoms, as well as the incidence, prevalence, and severity of other major neurological disorders.

98
article thumbnail

Eli Lilly selects new EVP of Global Quality

European Pharmaceutical Review

Eli Lilly and Company has announced its new Executive Vice President of Global Quality. This news follows a statement by the firm at the start of this year declaring the retirement of its long-serving current EVP. A new start at Eli Lilly Melissa Seymour will begin her new role as EVP at Eli Lilly on 22 July 2024. As part of this position, she will also serve as a member of the company’s Executive Committee.

article thumbnail

GSK shares fall 9% in wake of Zantac court ruling

Pharmaceutical Technology

Monday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE) following a Delaware judge’s ruling on 31 May that over 72,000 lawsuits over discontinued heartburn drug Zantac, known generically as ranitidine, could go ahead.

97
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

ASCO: Moderna may file melanoma vaccine on phase 2b data

pharmaphorum

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme.

102
102
article thumbnail

Sword Health Secures $130M, Introduces AI Care Specialist

MedCity News

With its financing round of $130 million, Sword Health is now valued at $3 billion. The company also unveiled Phoenix, an AI care specialist that guides users through sessions. The post Sword Health Secures $130M, Introduces AI Care Specialist appeared first on MedCity News.

104
104
article thumbnail

The IMA Group at ACHEMA 2024 : All-In-One solutions for the pharmaceutical sector

European Pharmaceutical Review

In an area covering almost 1,400m 2 , the Pharmaceutical Divisions of IMA Group and its specialists are glad to introduce IMA Pharma, the All-In-One supplier specialised in the design and manufacture of innovative machines and complete lines for the processing and packaging of pharmaceutical and nutraceutical products, medical devices assembling, as well as projects concerning digitalisation , sustainability, and customer service solutions.

article thumbnail

How AI and Machine Learning Can Transform Pharmacy Benefits Management

MedCity News

Abarca executives see plenty of potential for new technologies but note the need to strike the right balance between tech and human intervention. The post How AI and Machine Learning Can Transform Pharmacy Benefits Management appeared first on MedCity News.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

NIH AI tool predicts cancer patients’ immunotherapy outcomes

Pharmaceutical Technology

Scientists at the NIH have introduced an AI tool to predict the response to immune checkpoint inhibitors for cancer patients.

Patients 112
article thumbnail

FDA panel votes against Lykos’ pioneer psychedelic therapy

pharmaphorum

FDA advisors voted against the use of Lykos Therapeutics’ MDMA-based therapy for PTSD, in a first regulatory test for the emerging psychedelics sector

FDA 93
article thumbnail

ASCO 2024: Alligator shares positive data for pancreatic cancer drug

Pharmaceutical Technology

Alligator Bioscience’s CEO says that its pancreatic cancer drug may mark a meaningful improvement on current treatment standards.

109
109
article thumbnail

Unlocking emerging topics in research with Research Horizon Navigator

Clarivate

Learn how a new module within InCites Benchmarking & Analytics can help you see the leading edge of research. In a fundamentally uncertain world, scientific and academic research serves to make unknowns known, one small step at a time. Yet due to the ever-expanding volume of research published worldwide and the complexity of organizational and researcher networks, it can be challenging to identify early breakthroughs and understand the extent to which your organization is participating in th

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex

Pharmaceutical Technology

EryDex is being evaluated in the Phase III NEAT study which will enrol over 100 patients with rare disease ataxia-telangiectasia.

FDA 97
article thumbnail

Hospital Operating Margins Are Growing — But Not For All

MedCity News

Hospitals’ finances improved in April compared to both the month prior and the same time frame last year, according to a new report from Kaufman Hall. The report also noted that there is a widening gap between the highest- and lowest-performing organizations. The post Hospital Operating Margins Are Growing — But Not For All appeared first on MedCity News.

article thumbnail

ASCO 2024: Sanofi’s Sarclisa looks to gain an edge in multiple myeloma

Pharmaceutical Technology

Sarclisa is looking to make a dent in the anti-CD38 multiple myeloma treatment market dominated by J&J’s Darzalex.

article thumbnail

Finding a More Optimal Way for ATMPs (BIO 2024)

PharmaTech

Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

invoX Pharma’s FS222 delivers encouraging solid tumour treatment results

PharmaTimes

Positive clinical data from phase 1 study presented at ASCO annual meeting

88
article thumbnail

Unlock Social Insights to Drive Pharma Marketing Performance

PharmExec

As the digital and social media revolution continues to evolve, healthcare marketers must consider how to unlock the full potential of social with innovative engagement opportunities.

article thumbnail

BIOSECURE Act could impact US biopharma drugs with half in clinical-stage development

Pharmaceutical Technology

The BIOSECURE Act could impact more than 120 US biopharmaceutical drugs in development by companies partnered with Chinese contract development and manufacturing organisations (CDMOs) and biotechnology companies.

article thumbnail

Moderna, Merck Present Promising Trial Data for a Combination of V940 with Keytruda for the Treatment of High-Risk Melanoma Following Complete Resection

PharmExec

After three years of study, the V940 and Keytruda combination demonstrated sustained benefits in recurrence-free survival and distant metastasis-free survival in patients with high-risk melanoma following complete resection.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Compliance in the Spotlight: Building a Culture of Ethical Sales Practices

Rep-Lite

When it comes to medical sales, compliance and ethical practices have taken center stage. Ethical medical sales practices encompass a range of principles and guidelines aimed at ensuring patient safety, regulatory adherence, fair competition, and ethical conduct in sales interactions. With increasing scrutiny from regulatory bodies, healthcare institutions, and stakeholders, the spotlight is on companies to uphold ethical standards, avoid conflicts of interest, and prioritize patient well-being

Ethics 52
article thumbnail

Sarclisa Combination Improves Progression-Free Survival in Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma

PharmExec

Reportedly, data from the IMROZ study marks the first time an anti-CD38 monoclonal antibody combined with standard-of-care therapy has demonstrated significant improvement in progression-free survival for newly diagnosed transplant-ineligible multiple myeloma.

article thumbnail

The Impact of Medicare Part D Antidementia Medication Therapy Management on Adherence

Pharmaceutical Commerce

A retrospective study explores the connection between adherence and racial/ethnic disparities among patients with Alzheimer’s disease, along with similar dementias.

article thumbnail

What’s in a drug name? More than you might think.

PharmaVoice

From regulatory restrictions to evocative letter strings, branded drug naming is both an art and a science. We break down the process.

59
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A